As a continuation of its scientific strategy initiated in 2022 to support research on pancreatic cancer, and following the success of the PANCRÉAS 2022 edition, the ARC Foundation is launching in March the PANCRÉAS 2023 call for projects “Early detection of the efficacy of neoadjuvant therapy in pancreatic cancer”.
The objective of this call is to establish proof of concept for neoadjuvant therapy in pancreatic cancer. Projects will have to demonstrate early therapeutic efficacy, either in a classical neoadjuvant situation, or in inoperable patients with a medium/long term objective of integration in neoadjuvant strategies.
The expected projects will consist of phase 1 and/or 2 clinical trials demonstrating early efficacy of neoadjuvant therapy, alone or in combination, in patients with pancreatic cancer.
More info : HERE
Project submission : HERE
Deadline > June 13th 2023
